biotech · Rheumatoid Arthritis · Pharmacokinetics · XBIT
XBiotech Germany
XBiotech Germany GmbH
XBiotech Germany trial registry — 8 ClinicalTrials.gov studies with program phase, status, and indication context.
Baesweiler, DE HQ
30 Employees
Public company Type
XBIT · NYSE Ticker
Company details
- Status
- Public
- HQ
- Baesweiler, DE
- Employees
- 30
- Programs
- 8
- Drugs
- 6
- Patents
- 31
XBiotech Germany clinical trials
Registry index of 8 ClinicalTrials.gov studies linked to XBiotech Germany programs — each row shows trial ID, program name, phase, status, and indication.
XBiotech Germany trial registry — 8 ClinicalTrials.gov studies with program phase, status, and indication context.
Recent trial activity
Latest clinical program signals indexed for XBiotech Germany.
-
XB2001 or Placebo — Phase 2
Clinical update -
Natrunix with MTX placebo (+folate) — Phase 2
Clinical update -
514G3 (2 mg/kg) plus standard IV antibiotic treatment — Phase 2
Clinical update -
Natrunix — Phase 2
Clinical update -
Natrunix 400 mg — Phase 2
Clinical update -
vilamakitug — Phase 2
Clinical update -
Hutrukin — Phase 1
Clinical update -
NatrunixTM — Phase 1
Clinical update